Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease. - Wikidata - awgldk - TriplyDB

Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease.

Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease.

http://www.wikidata.org/entity/Q34500168

about

Polycystin-1: a master regulator of intersecting cystic pathways Polycystic liver diseases: advanced insights into the molecular mechanisms Rare cystic liver lesions: a diagnostic and managing challenge.Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.Sec63 and Xbp1 regulate IRE1α activity and polycystic disease severity.Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure.Therapeutic Targets in Polycystic Liver Disease.Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24 MLH1 and MSH2 Gene Variants.Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling.Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene.

P2860

Q26826955-387625C7-85BC-4F00-8B8A-3CF0327DA6D8 Q27001174-408B6CC0-138B-4C8D-9576-29B76BD82245 Q30446819-F1191425-F43A-47F4-907A-877FB94B0F79 Q33648233-77584DF8-75A7-4C6C-A6D6-E80F8764D6E1 Q35719978-4ADDBB44-C207-4602-A104-68A81D302892 Q37379190-BAE3197A-2F0D-4C44-91D1-F168D59CAF64 Q38443908-F08C5F91-CFA5-4BF8-B079-5AC8291C2CAD Q39389539-5A4DB513-CA73-4403-8E65-EAEA4A85ED0E Q47137161-2055706C-EC1F-4C62-B028-90C9FF5C2A54 Q47706205-E3FE252F-85F0-41E1-8FE3-3BC7B4F18F7A Q55043077-8C59C1CC-2DE1-4BB8-B97D-D86EE4D20F5E

P2860

Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease.

http://www.wikidata.org/entity/Q34500168

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Loss of heterozygosity is pres ...... with polycystic liver disease.

@ast

Loss of heterozygosity is pres ...... with polycystic liver disease.

@en

Loss of heterozygosity is pres ...... with polycystic liver disease.

@nl

type

label

Loss of heterozygosity is pres ...... with polycystic liver disease.

@ast

Loss of heterozygosity is pres ...... with polycystic liver disease.

@en

Loss of heterozygosity is pres ...... with polycystic liver disease.

@nl

prefLabel

Loss of heterozygosity is pres ...... with polycystic liver disease.

@ast

Loss of heterozygosity is pres ...... with polycystic liver disease.

@en

Loss of heterozygosity is pres ...... with polycystic liver disease.

@nl

P1433

Q34500168-359F0AF2-CC42-4B89-8A98-4695E9F9A06E

P1476

Q34500168-5EAD48FF-AF74-4629-8382-0A24BD0E4B0E

P2093

Q34500168-46370AE2-CBBA-4646-8DD6-D028351EE226

Q34500168-46EBB10A-9ADD-4869-9FB6-E9DD698818C9

Q34500168-7008173C-97F1-4598-9046-EEE29DA0BBEF

Q34500168-B903C613-D055-47B4-96FB-5280618F57E4

P2860

Q34500168-0098B396-7840-49ED-8C9F-63EFD37A7570

Q34500168-01304A50-7718-4FA9-B807-2007BE89F768

Q34500168-0B0528E8-BC7F-48B2-887E-3E0A8EED872A

Q34500168-0C71519D-FDC4-4BF5-9CFA-F37E2BC73DAE

Q34500168-1E614DEE-B2B8-4375-9228-8CB1EE3D98DF

Q34500168-4704D68D-CE38-4D0F-9F5F-07238B4A3DBC

Q34500168-4E82A065-0AB0-43A3-AF84-AF3D02E1B819

Q34500168-5A3B0917-2409-45FB-B730-C6A06A818701

Q34500168-63425172-6403-4E1E-B1EF-D6A290438ADB

Q34500168-69CEDA1A-8CEC-4A65-888D-7E7B5A0292FB

P304

Q34500168-DE0F16F9-2B41-48B6-B3C1-7B03A1779390

P31

Q34500168-8C9A3E5E-F4E7-43FE-848F-E16FB394A714

P356

Q34500168-AF594271-886C-4FA9-BFAC-57CE96CC3922

P407

Q34500168-A3D71731-8055-441F-922D-87A31CFA8996

P433

Q34500168-1AAFF286-6BA5-4DA2-907D-935D51FC9A2D

P478

Q34500168-B6D68785-8814-4E4E-A699-FF16592B81B3

P577

Q34500168-9FBDD8B7-8236-4232-9396-D0D208205C7A

P5875

Q34500168-EBFA7FE4-793F-4829-8FCF-A8AA34BE4F1C

P698

Q34500168-B07F0105-F308-4608-8DB8-35A822EBC048

P932

Q34500168-3B8D57AA-73EA-4919-99D6-83FF84360E17

P356

JOURNAL.PONE.0050324

P1433

P1476

Loss of heterozygosity is pres ...... with polycystic liver disease.

@en

P2093

Jody Salomon

http://www.w3.org/2001/XMLSchema#string

Joost P H Drenth

http://www.w3.org/2001/XMLSchema#string

Manoe J Janssen

http://www.w3.org/2001/XMLSchema#string

René H M Te Morsche

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease.

A mosaic activating mutation in AKT1 associated with the Proteus syndrome

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease

Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells

Mutations in SEC63 cause autosomal dominant polycystic liver disease

Two-sided confidence intervals for the single proportion: comparison of seven methods

A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation

Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63.

Improved resolution by mounting of tissue sections for laser microdissection.

P304

e50324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0050324

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233840843

http://www.w3.org/2001/XMLSchema#string

P698

23209713

http://www.w3.org/2001/XMLSchema#string

P932

3508994

http://www.w3.org/2001/XMLSchema#string